EG666504 Activators
Transmembrane protein 249 activators encompass a diverse set of chemical compounds that exert their effects through modulation of signaling pathways and phosphorylation events which, in turn, lead to the enhanced activation of transmembrane protein 249. Forskolin, through its action on adenylyl cyclase, increases the levels of cAMP, which is a pivotal second messenger in cellular signaling. The increased cAMP levels activate PKA, which is known to phosphorylate myriad proteins that either directly interact with or are part of the signaling network to which transmembrane protein 249 belongs, thereby enhancing its activity. Similarly, the elevation of intracellular calcium levels by ionomycin leads to the activation of calmodulin-dependent kinases, which phosphorylate proteins that could interact with or be part of the transmembrane protein 249 signaling cascade.
The use of PMA activates PKC, a kinase that phosphorylates serine and threonine residues on myriad proteins. This phosphorylation can impact the signaling pathways transmembrane protein 249 is involved in, thus indirectly enhancing its activity. In parallel, the inhibition of protein phosphatases by Calyculin A and Okadaic acid results in an increased phosphorylation state of proteins, thereby potentially enhancing the functional activity of transmembrane protein 249 by maintaining the activation state of its signaling partners. Anisomycin, through its activation of stress-activated protein kinases, can also influence the signaling milieu of transmembrane protein 249.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels, which can activate calmodulin-dependent protein kinases. These kinases can phosphorylate and alter the function of proteins within the same signaling pathways as transmembrane protein 249, indirectly leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on proteins. PKC-mediated phosphorylation can enhance the functional activity of proteins in the same pathway or directly associated with transmembrane protein 249. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
By inhibiting protein phosphatases 1 and 2A, calyculin A prevents the dephosphorylation of proteins, thereby maintaining them in an activated state. This can indirectly enhance the activity of transmembrane protein 249 by sustaining the phosphorylation state of proteins within its signaling network. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to calyculin A, okadaic acid inhibits protein phosphatases, leading to increased phosphorylation levels within the cell. The resulting phosphorylation pattern can enhance the functional activity of transmembrane protein 249 by affecting its associated signaling proteins. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs), which can phosphorylate regulatory proteins. This activation cascade can influence proteins that are functionally related to transmembrane protein 249, enhancing its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 selectively inhibits p38 MAP kinase, which can lead to the alteration of downstream signaling pathways. These changes can enhance the functional activity of proteins in the same pathway or interacting with transmembrane protein 249. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that, by altering the PI3K/AKT signaling pathway, can influence the phosphorylation states and activity of proteins associated with transmembrane protein 249, leading to its enhanced activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which normally phosphorylates and activates ERK in the MAPK pathway. Alterations in this pathway can indirectly lead to the enhanced activity of transmembrane protein 249 by affecting the proteins that regulate or interact with it. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that prevents the activation of ERK, influencing the MAPK pathway. This can lead to enhanced functional activity of proteins that are in the same signaling pathway or directly interact with transmembrane protein 249. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Inhibition of CaMKII can lead to compensatory effects within the cell's signaling networks, potentially enhancing the functional activity of proteins associated with transmembrane protein 249. | ||||||